Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems
Acta Diabetologica · 2024
DOI: 10.1007/s00592-024-02397-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Acta Diabetologica, 2024. Verfasst von Nicolò Diego Borella und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Endocrine Diseases and Diabetology, Department of Medicine, ASST Papa Giovanni XXIII, Piazza OMS, 1, 24127, Bergamo, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Insulin, Blood Glucose. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: partially funded by the National Plan for NRRP Complementary Investments.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Advanced hybrid closed loop (AHCL) systems currently represent the most advanced modality of insulin therapy.
Aim
To compare the night-time (from 00 to 07 a.m.) effectiveness in achieving recommended glycemic targets of three different AHCL systems in adults with type 1 diabetes (T1D).
Methods
We retrospectively evaluated 55 adults with T1D (mean age 41 ± 16 years, male 40%, diabetes duration 19.4 ± 11.4 years, BMI 24.1 ± 4.1 kg/m 2 ) with similar glycemic control (GMI 7.0–7.4%). Twenty-two participants were using the Minimed 780G system, 18 the Tandem t:slim X2 with Control-IQ system and 15 the DBLG1 system. Continuous glucose monitoring derived metrics and insulin requirement of 14 consecutive nights were analyzed.
Results
All three groups achieved the recommended mean TIR > 70%, mean TBR < 4%, and mean CV < 36% with a similar insulin requirement (Minimed 780G system: TIR 73.9 ± 11.2%, TBR 0.9 ± 1.2%, CV 29 ± 6.7%; Tandem t:slim X2 with Control-IQ system: TIR 74.1 ± 11.1%, TBR 1.1 ± 1.0%, CV 34.5 ± 6.6%; DBLG1 System TIR 71.7 ± 11.3%, TBR 1.4 ± 3.7%, CV 32.4 ± 7.1%). Tight TIR% (70–140 mg/dl) was significantly higher (p < 0.01) in the Tandem t:slim X2 with Control-IQ group (51.5 ± 9.8%) when compared to Minimed 780G group (42.1 ± 13.7%) and DBLG1 System (40.1 ± 10.5%). In all three groups the insulin infusion similarly decreased from midnight to 05.00 am and then increased.
Conclusions
All the three AHCL systems achieved the recommended TIR, TBR and CV without difference in insulin requirement. The Tandem Control-IQ system obtained a higher tight TIR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unit of Endocrine Diseases and Diabetology, Department of Medicine, ASST Papa Giovanni XXIII, Piazza OMS, 1, 24127, Bergamo, Italy.
- Control Systems and Automation Laboratory, Department of Management, Information and Production Engineering, University of Bergamo, Bergamo, Italy.
- Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.
- Unit of Endocrine Diseases and Diabetology, Department of Medicine, ASST Papa Giovanni XXIII, Piazza OMS, 1, 24127, Bergamo, Italy. glepore@assst.pg23.it.
Förderung
- partially funded by the National Plan for NRRP Complementary Investments
Zitieren
APA
Borella, N. D., Ferramosca, A., Castagna, G., Ippolito, S., Ceresoli, S., Taverna, A., Sonzogni, B., Trevisan, R., & Lepore, G. (2024). Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems. Acta Diabetologica. https://doi.org/10.1007/s00592-024-02397-9
Vancouver
Borella ND, Ferramosca A, Castagna G, Ippolito S, Ceresoli S, Taverna A, et al. Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems. Acta Diabetologica. 2024. doi:10.1007/s00592-024-02397-9
BibTeX
@article{Borella2024,
author = {Borella, Nicolò Diego and Ferramosca, Antonio and Castagna, Giona and Ippolito, Silvia and Ceresoli, Sara and Taverna, Antonio and Sonzogni, Beatrice and Trevisan, Roberto and Lepore, Giuseppe},
title = {Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems},
journal = {Acta Diabetologica},
year = {2024},
doi = {10.1007/s00592-024-02397-9}
}
EUVIMED